Literature DB >> 21300459

Visual outcome in meningiomas around anterior visual pathways treated with linear accelerator fractionated stereotactic radiotherapy.

Hadas Stiebel-Kalish1, Ehud Reich, Lior Gal, Zvi Harry Rappaport, Ouzi Nissim, Raphael Pfeffer, Roberto Spiegelmann.   

Abstract

PURPOSE: Meningiomas threatening the anterior visual pathways (AVPs) and not amenable for surgery are currently treated with multisession stereotactic radiotherapy. Stereotactic radiotherapy is available with a number of devices. The most ubiquitous include the gamma knife, CyberKnife, tomotherapy, and isocentric linear accelerator systems. The purpose of our study was to describe a case series of AVP meningiomas treated with linear accelerator fractionated stereotactic radiotherapy (FSRT) using the multiple, noncoplanar, dynamic conformal rotation paradigm and to compare the success and complication rates with those reported for other techniques. PATIENTS AND METHODS: We included all patients with AVP meningiomas followed up at our neuro-ophthalmology unit for a minimum of 12 months after FSRT. We compared the details of the neuro-ophthalmologic examinations and tumor size before and after FSRT and at the end of follow-up.
RESULTS: Of 87 patients with AVP meningiomas, 17 had been referred for FSRT. Of the 17 patients, 16 completed >12 months of follow-up (mean 39). Of the 16 patients, 11 had undergone surgery before FSRT and 5 had undergone FSRT as first-line management. Tumor control was achieved in 14 of the 16 patients, with three meningiomas shrinking in size after RT. Two meningiomas progressed, one in an area that was outside the radiation field. The visual function had improved in 6 or stabilized in 8 of the 16 patients (88%) and worsened in 2 (12%).
CONCLUSIONS: Linear accelerator fractionated RT using the multiple noncoplanar dynamic rotation conformal paradigm can be offered to patients with meningiomas that threaten the anterior visual pathways as an adjunct to surgery or as first-line treatment, with results comparable to those reported for other stereotactic RT techniques.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21300459     DOI: 10.1016/j.ijrobp.2010.12.017

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery.

Authors:  Putipun Puataweepong; Mantana Dhanachai; Ake Hansasuta; Somjai Dangprasert; Chomporn Sitathanee; Rawee Ruangkanchanasetr; Pornpan Yongvithisatid
Journal:  J Neurooncol       Date:  2018-05-30       Impact factor: 4.130

2.  Radiosurgical decompression for benign perioptic tumors causing compressive cranial neuropathies: a feasible alternative to microsurgery?

Authors:  Eun Jung Lee; Young Hyun Cho; KyoungJun Yoon; Byungchul Cho; Eun Suk Park; Chang Jin Kim; Sung Woo Roh
Journal:  J Neurooncol       Date:  2016-09-06       Impact factor: 4.130

3.  Endocrine and visual function after fractionated stereotactic radiotherapy of perioptic tumors.

Authors:  M Kocher; H Treuer; M Hoevels; R Semrau; V Sturm; R-P Mueller
Journal:  Strahlenther Onkol       Date:  2012-12-20       Impact factor: 3.621

4.  Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM.

Authors:  Leor Zach; Amir Agami; Orit Furman; Moshe Attia; Zvi Cohen; Iris Ben-Bassat Mizrachi; Guy Tam; Zion Zibly; Ouzi Nissim; Roberto Spiegelmann; Ruth Huna-Baron
Journal:  Radiat Oncol       Date:  2021-08-28       Impact factor: 3.481

5.  Visual outcome after fractionated stereotactic radiation therapy of benign anterior skull base tumors.

Authors:  Arnar Astradsson; Anne Katrine Wiencke; Per Munck af Rosenschold; Svend-Aage Engelholm; Lars Ohlhues; Henrik Roed; Marianne Juhler
Journal:  J Neurooncol       Date:  2014-02-15       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.